Eden Tirzepatide Cost: What You'll Actually Pay Per Month

How much does Eden's tirzepatide actually cost per month?

Eden's homepage leads with one number: $199 a month for compounded tirzepatide. That figure is accurate, but it's also only half of what actually lands on your card once you enroll.

Getting that medication requires an active Eden Membership, billed as a separate line: $39 for your first month, then $99 a month going forward. Add the two together and the honest ongoing price is $298 a month — with your very first month closer to $238, since the membership starts at its discounted rate.

Eden appears to have restructured its pricing at some point in 2026, moving from a single all-inclusive monthly charge to this two-line medication-plus-membership model. A few older pricing roundups still cite a flat $329 figure with no separate fee at all — that no longer matches what three independent, more recent pricing reviews found on Eden's current checkout flow. Budget against $298 a month, not an older number you might come across elsewhere.

Does the price change by dose — is there a titration ladder?

No, and this is one of Eden's clearest advantages in a category where the bill often climbs alongside your dose. Eden's compounded tirzepatide holds at $199 a month whether you're just starting at the lowest titration step or you've worked up to a full maintenance dose months later. The $99 membership stays flat too, so your combined $298 a month doesn't move regardless of where you land on the dose curve.

That flat structure is worth appreciating against Medvi, whose compounded tirzepatide starts around $279 for an intro month and then climbs to $449-$499 a month once you reach a maintenance dose — a pattern that can add several hundred extra dollars to a year of treatment compared with Eden's flat rate.

Is there a separate membership fee, or is that the whole price?

There is a separate fee, and it's the detail most worth sitting with before you hand over payment information. Eden's own site states plainly that medication is not available without an active membership, and separately, that the membership itself does not include or guarantee a prescription. Practically, that means your first $39 charge buys you a provider evaluation — not a guaranteed outcome, and not the $199 medication charge, which only starts once a clinician actually approves treatment.

That's a meaningfully different structure than Henry Meds, which bundles the clinician visit into one all-in medication price with no separate membership line at all. At Eden, you're paying for two things — the clinical relationship and the drug — and only one of them is guaranteed by paying it.

What's actually included in the price — and what costs extra?

• Membership ($39 first month, then $99/mo): provider access and evaluation, care-team messaging, ongoing coordination — does not itself include or guarantee a prescription
• Medication charge ($199/mo flat): the compounded tirzepatide injection itself, injection supplies, and expedited shipping
• Not included: baseline or monitoring labs — left to your provider's discretion and billed separately if ordered
• Not included: insurance billing — compounded tirzepatide has no insurance pathway anywhere in this category, Eden included
• Accepted: HSA and FSA cards at checkout for both the membership and medication charges

One more practical note: Eden's tirzepatide ships as an injection only. Tirzepatide has no FDA-approved oral form at all, so unlike Medvi or Henry Meds — both of which sell a compounded oral tablet version — Eden doesn't offer a pill workaround to compare against its injection price.

Eden vs. Zepbound — which actually costs less?

At the very lowest dose tier, the two are close to a wash: Eden's $298-a-month all-in price sits almost exactly where Zepbound's LillyDirect self-pay floor starts, at $299 for the 2.5mg starter dose. Move past that starting point and Eden pulls ahead — its flat rate holds at $298 while Zepbound's own self-pay ladder climbs to $399 at 5mg and levels off at a $449 ceiling from 7.5mg through the highest maintenance doses.

Zepbound also has a lever Eden doesn't: a manufacturer savings card that can bring the price as low as $25 a month if your commercial insurance covers it, alongside full FDA approval for the finished drug rather than a pharmacy-compounded version of the same molecule. Eden's compounded product currently sits under an FDA warning letter over how that compounded status was marketed — cost and legitimacy are different questions, but related enough to weigh together.

How does Eden compare to other tirzepatide telehealth providers?

Medvi — cheaper first month, pricier once you titrate

Medvi's discounted first month, around $279, genuinely beats Eden's $238 first-month total by a small margin — but that's the only point in the comparison where Medvi wins. Push into month two and Medvi's dose-tiered ladder climbs to $399, then $449-$499 at maintenance, while Eden holds flat at $298. By month four or five, Eden is the meaningfully cheaper option.

Henry Meds — no membership line, but a higher ceiling

Henry Meds prices injectable tirzepatide at a flat $449 a month, all-in, with no separate membership fee to track. Eden's combined $298 a month undercuts that by roughly $151 a month, even though Eden's structure technically involves two charges instead of Henry Meds' one. The tradeoff is billing simplicity: Henry Meds is a single line item, Eden is two that renew independently.

Mochi Health — the one competitor that's actually cheaper

This is the comparison Eden's marketing doesn't emphasize. Mochi Health charges the identical $199 a month for its compounded tirzepatide medication, but its membership runs $79 a month rather than Eden's $99 — landing Mochi's all-in total at $278 a month, about $20 cheaper than Eden every single month. Both platforms use the same two-part, dual-subscription structure, so the billing complexity is a wash; the $20-a-month gap is real money over a year.

The overall pattern: Eden's flat-rate pricing beats most of the dose-tiered competition once you're past an intro month, but it isn't automatically the cheapest option in the category — Mochi Health currently is, by a modest but consistent margin.

What does a real year of Eden tirzepatide cost?

Because Eden's price never climbs with dose, the annual math is simpler than most of its competitors'. One discounted first month at $238, followed by eleven months at $298, lands a full year at roughly $3,516 — a number that several independent pricing reviews converge on directly.

For context, that's meaningfully below Henry Meds' flat $5,388-a-year injectable ceiling and Medvi's dose-tiered range of roughly $5,100 to $6,100 a year, but a bit above Mochi Health's approximately $3,336-a-year total for the same medication. Where you land in that range matters more over twelve months than it does in any single month's bill.

Does insurance, HSA/FSA, or a coupon lower Eden's price?

Insurance doesn't apply here — compounded tirzepatide has no billing pathway through commercial insurance or Medicare, at Eden or anywhere else in this category. HSA and FSA cards are accepted at checkout for both the membership and medication charges, which can meaningfully lower your effective cost depending on your tax bracket, though whether your specific plan reimburses a weight-management purchase is worth confirming with your plan administrator rather than assuming.

There's no manufacturer savings card the way there is for brand-name Zepbound — that lever simply doesn't exist for a compounded product. Eden does advertise a Weight Loss Warranty, a money-back guarantee tied to a body-weight-loss benchmark within a set window, subject to its own terms; it's worth reading the fine print directly rather than treating it as a blanket refund policy.

Is Eden legit — and does the price reflect that?

The pricing structure itself isn't a bait-and-switch — the $298-a-month figure is genuinely what most patients land on, and it's consistent across independent sources. The bigger legitimacy question sits with the FDA. On June 8, 2026, the agency sent a warning letter to Eden Health International Inc., citing product labeling that misidentified who compounded Eden's medications and website language describing its pharmacy partners as "FDA-licensed" — a designation the FDA doesn't actually grant to compounding facilities.

Separately, Eden carries an F rating with the Better Business Bureau, unaccredited, with over 100 complaints on file — the dominant theme is billing and auto-renewal, which lines up directly with the two-part membership-plus-medication structure driving the price advantage covered above. Trustpilot tells a more favorable story at roughly 4.5 out of 5 across nearly 4,700 reviews, with a smaller but consistent thread of complaints about portal issues and slow prescription-refill communication. None of that erases Eden's real cost advantage over several competitors — but it's worth weighing alongside the number, not instead of it.

Which Eden plan actually fits your budget?

• You expect to reach a full maintenance dose and want a price that won't climb → Eden's flat $298/mo all-in beats Medvi's dose-tiered $449-$499/mo maintenance range and Henry Meds' $449/mo injectable ceiling.
• You want the single cheapest all-in compounded tirzepatide, full stop → Mochi Health's $278/mo edges out Eden by about $20 a month, for the same $199 medication price.
• You'd rather have one charge than two → Henry Meds' single $449/mo line has no separate membership to track, even though it costs more.
• You have commercial insurance that covers Zepbound → the manufacturer savings card can beat every compounded option here, Eden included — see Zepbound cost.
• Billing-complaint history matters to you as much as the price → weigh Eden's BBB record and its non-guaranteed membership structure against the flat rate before enrolling.